Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
2019637 citationsVisanu Thamlikitkul et al.profile →
Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
2011567 citationsVisanu Thamlikitkul et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Visanu Thamlikitkul
Since
Specialization
Citations
This map shows the geographic impact of Visanu Thamlikitkul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Visanu Thamlikitkul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Visanu Thamlikitkul more than expected).
Fields of papers citing papers by Visanu Thamlikitkul
This network shows the impact of papers produced by Visanu Thamlikitkul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Visanu Thamlikitkul. The network helps show where Visanu Thamlikitkul may publish in the future.
Co-authorship network of co-authors of Visanu Thamlikitkul
This figure shows the co-authorship network connecting the top 25 collaborators of Visanu Thamlikitkul.
A scholar is included among the top collaborators of Visanu Thamlikitkul based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Visanu Thamlikitkul. Visanu Thamlikitkul is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Tongsai, Sasima, et al.. (2020). Comparative Effectiveness and Safety of Original Gabapentin and Generic Gabapentin in Treating Patients with Neuropathic Pain at Siriraj Hospital, Bangkok, Thailand. SHILAP Revista de lepidopterología.1 indexed citations
7.
Thamlikitkul, Visanu, et al.. (2016). Monitoring of Effectiveness and Safety of Colistin for Therapy in Resistant Gram-Negative Bacterial Infections in Hospitalized Patients at Siriraj Hospital.. PubMed. 99(3). 301–7.11 indexed citations
8.
Rattanaumpawan, Pinyo, et al.. (2016). Accuracy of ICD-10 Coding System for Identifying Comorbidities and Infectious Conditions Using Data from a Thai University Hospital Administrative Database.. PubMed. 99(4). 368–73.9 indexed citations
9.
Sirijatuphat, Rujipas, et al.. (2015). Implementation of antibiotic use guidelines for fresh traumatic wound at Siriraj Hospital.. PubMed. 98(3). 245–52.4 indexed citations
10.
Thamlikitkul, Visanu. (2014). STOP Antimicrobial Resistance: Everybody’s Business. SHILAP Revista de lepidopterología.3 indexed citations
11.
Tongsai, Sasima, et al.. (2013). Effectiveness and safety of generic formulation of piperacillin/tazobactam (Astaz-P) for treatment of infected patients at Siriraj Hospital.. PubMed. 96 Suppl 2. S104–10.3 indexed citations
12.
Tiengrim, Surapee, Sudaluck Thunyaharn, Woraphot Tantisiriwat, et al.. (2012). Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections.. PubMed. 95 Suppl 2. S6–17.18 indexed citations
Thamlikitkul, Visanu, et al.. (2011). Microbiological equivalence of bacteriostatic and bactericidal activities of the sera from healthy volunteers receiving generic piperacillin/tazobactam (Pipertaz) and original piperacillin/tazobactam (Tazocin).. PubMed. 94 Suppl 1. S196–202.1 indexed citations
15.
Angkasekwinai, Nasikarn, et al.. (2011). Monitoring of effectiveness and safety of generic formulation of meropenem for treatment of infections at Siriraj Hospital.. PubMed. 94 Suppl 1. S217–24.6 indexed citations
16.
Thamlikitkul, Visanu, et al.. (2010). Microbiological equivalence of serum bacteriostatic and bactericidal activities of the sera from healthy volunteers receiving original meropenem (Meronem) and generic meropenem (Mero).. PubMed. 93 Suppl 1. S110–6.2 indexed citations
Thamlikitkul, Visanu, et al.. (2006). Effectiveness of the Royal Thai Traditional Massage for Relief of Muscle Pain. SHILAP Revista de lepidopterología.2 indexed citations
19.
Chavalittumrong, Pranee, et al.. (2006). Clinical Study of Morus Alba Linn. on Glycemic Control and Blood Lipids in Patients with Type 2 Diabetes: A Preliminary Study. SHILAP Revista de lepidopterología.2 indexed citations
20.
Thamlikitkul, Visanu, et al.. (2002). Use of Alternative Medicines among Medical Patients at Siriraj Hospital. SHILAP Revista de lepidopterología.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.